115 related articles for article (PubMed ID: 7458579)
1. Kinetics of the graft versus host reaction during allogeneic tumour enhancement.
Piazzon I; Déroche A; Pasqualini CD
Arch Geschwulstforsch; 1980; 50(4):322-6. PubMed ID: 7458579
[TBL] [Abstract][Full Text] [Related]
2. Conditions favoring immunological enhancement of a murine allogeneic lymphoma.
Rumi L; Colmerauer ME; Pasqualini CD
Arch Geschwulstforsch; 1976; 46(6):457-60. PubMed ID: 63273
[TBL] [Abstract][Full Text] [Related]
3. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
4. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
Wander RH; Hilgard HR
J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
[TBL] [Abstract][Full Text] [Related]
5. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
[TBL] [Abstract][Full Text] [Related]
6. The allogeneic effect in (Balb/c X AKR)F1 mice.
Rózalska B
Arch Immunol Ther Exp (Warsz); 1983; 31(4):423-7. PubMed ID: 6367696
[TBL] [Abstract][Full Text] [Related]
7. Specific depletion of graft-versus-host activity of normal or allosensitized parental spleen cells.
Rózalska B
Arch Immunol Ther Exp (Warsz); 1983; 31(4):417-21. PubMed ID: 6200087
[TBL] [Abstract][Full Text] [Related]
8. Specific partial depletion of graft-vs-host activity by incubation and centrifugation of mouse spleen cells on allogeneic spleen cell monolayers.
Mage MG; McHugh LL
J Immunol; 1975 Oct; 115(4):911-3. PubMed ID: 240886
[TBL] [Abstract][Full Text] [Related]
9. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
Johnson BD; Drobyski WR; Truitt RL
Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
[TBL] [Abstract][Full Text] [Related]
10. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
11. Development of tumors as a result of graft-versus-host reaction.
Cornelius EA
Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
[No Abstract] [Full Text] [Related]
12. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
[TBL] [Abstract][Full Text] [Related]
13. [Functional lymphoma capable of restoring the thymic response of an allogeneic mouse].
Piazzon I; Déroche A; Matusevich M; Pasqualini CD
Medicina (B Aires); 1979; 39(3):351-6. PubMed ID: 42002
[No Abstract] [Full Text] [Related]
14. Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy.
Chester SJ; Esparza AR; Albala MM
Cancer Res; 1975 Mar; 35(3):634-6. PubMed ID: 234788
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
[TBL] [Abstract][Full Text] [Related]
18. Participation of IL-2 and direct cell cytotoxicity in the modulation of GvH reaction in mice infected with Listeria innocua.
Gościcka T; Walencka M; Szeliga J; Bloch M; Dziadek B
Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):239-45. PubMed ID: 8744642
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical behaviour of a tumour-associated antigen obtained from an AKR mouse lymphoma.
Hajos SE; Alvarez E; Pierangeli S; Margni RA; Pasqualini CD
Vet Immunol Immunopathol; 1985 Jan; 8(1-2):157-69. PubMed ID: 3976168
[TBL] [Abstract][Full Text] [Related]
20. An investigation into the influence of a graft-versus-host reaction, induced by parent line cells, on the growth of lymphoma transplants in F1 hybrid mice.
Palmer AM; Symes MO
Folia Biol (Praha); 1974; 20(1):26-35. PubMed ID: 4154872
[No Abstract] [Full Text] [Related]
[Next] [New Search]
